Recently, TGF-β has been shown to be involved in the conversion of NK cells to ILC1-like cells, via a JNK-dependent, Smad4-independent pathway resulting in reduced cytotoxicity in murine tumor models (26, 27). The gene discussed is SMAD4; the disease is neoplasm.